وثيقة

Applicability of the existing CVD risk assessment tools to Type II diabetics in Oman : a review.

المعرف
DOI 10.5001/omj.2015.65
المساهمون
Lee, Patricia., مؤلف
الناشر
Oman Medical Specialty Board.
ميلادي
2015-09
اللغة
الأنجليزية
الملخص الإنجليزي
Patients with type II diabetes (T2DM) have an elevated risk for cardiovascular disease (CVD), and it is considered to be a leading cause of morbidity and premature mortality in these patients. Many traditional risk factors such as age, male sex, hypertension, dyslipidemia, glycemic control, diabetes duration, renal dysfunction, obesity, and smoking have been studied and identified as independent factors for CVD. Quantifying the risk of CVD among diabetics using the common risk factors in order to plan the treatment and preventive measures is important in the management of these patients as recommended by many clinical guidelines. Therefore, several risk assessment tools have been developed in different parts of the world for this purpose. These include the tools that have been developed for general populations and considered T2DM as a risk factor, and the tools that have been developed for T2DM populations specifically. However, due to the differences in sociodemographic factors and lifestyle patterns, as well as the differences in the distribution of various CVD risk factors in different diabetic populations, the external applicability of these tools on different populations is questionable. This review aims to address the applicability of the existing CVD risk models to the Omani diabetic population.
zcustom_txt_2
Al-Rawahi, Abdulhakeem, & Lee, Patricia (2015). Applicability of the existing CVD risk assessment tools to Type II diabetics in Oman : a review. Oman Medical Journal, 30 (5), 315-319.
قالب العنصر
مقالات الدوريات

مواد أخرى لنفس المؤلف

مقالات الدوريات
0
0
Al-Rawahi, Abdulhakeem.
Oman Medical Specialty Board.
2012-05
مقالات الدوريات
0
0
Al-Rawahi, Abdulhakeem.
Oman Medical Specialty Board.
2017-03
مقالات الدوريات
0
0
Al-Rawahi, Abdulhakeem.
Oman Medical Specialty Board.
2021-03

مواد أخرى لنفس الموضوع